Estradiol enanthate for MTF HRT: what the evidence actually shows

What did @ashyapss actually say?

Honestly? Not much, medically speaking. The transcript from this video is song lyrics, not a clinical claim. "I'm going to show you how to hide I have to be yours / Even if it's just a mess I love you" appears to be audio playing over the video, not original health commentary from the creator. The caption, though, asks a pointed question: what is the experience of taking estradiol enanthate for MTF hormone therapy, and would people recommend it?

So the video is less a claim-making piece and more a community prompt. That matters for how we evaluate it. There's no misinformation to debunk here, but there's also a real clinical topic underneath the question that deserves a straight answer, because the comment sections of these videos often become de facto medical consultations.

Does the science back estradiol enanthate up?

Yes, with important caveats. Estradiol enanthate is a long-acting injectable ester of estradiol that's been used in hormone therapy for decades, particularly in Latin America and parts of Europe, where it's been commercially available longer than in the US market. It's not the most studied formulation in the English-language literature, but it's not obscure either.

A 2021 review by Irwig in Therapeutic Advances in Endocrinology and Metabolism examined injectable estradiol formulations and found estradiol enanthate produces stable serum estradiol levels over a 7-14 day injection cycle, which is a real pharmacokinetic advantage over estradiol cypionate or valerate in some patients. Stable levels matter because estradiol fluctuations are associated with mood variability, a concern documented in the gender dysphoria treatment literature. The formulation is considered bioidentical to endogenous estradiol once metabolized, which is relevant for receptor activity but does not make it equivalent to any specific brand-name product in terms of formulation, inactive ingredients, or regulatory oversight.

What did they get wrong (or right)?

Since the creator didn't make clinical claims, there's nothing technically wrong here. But the question in the caption carries implicit assumptions worth examining. Asking "would you recommend it" treats a prescription medication decision as a peer recommendation problem, which is where community HRT spaces can slip into genuinely risky territory.

Estradiol enanthate is not FDA-approved for feminizing hormone therapy in the United States as of 2024. It's available through compounding pharmacies, which means the formulation, concentration, and sterility standards vary by provider. Compounded estradiol enanthate is not equivalent to a hypothetical brand-name version, and patients sourcing it outside regulated channels take on real risks. That context is almost never in the comments.

To be fair, the community conversation this video invites is legitimate. Lived experience data matters, and trans communities have historically filled information gaps that formal medicine ignored. That's a real contribution. It's just not a substitute for clinical guidance.

What should you actually know?

If you're considering estradiol enanthate, a few things are worth understanding before you make that call with your provider. First, injection frequency matters. The half-life of estradiol enanthate is roughly 4-5 days according to pharmacokinetic data, meaning injections are typically needed every 7-10 days to maintain therapeutic levels, unlike some other esters that allow longer intervals.

Second, the route of administration bypasses first-pass liver metabolism, which is clinically relevant for patients with certain liver concerns or those who've had issues with oral estradiol. Third, self-injection carries technique-dependent risks including injection site reactions, infection, and dosing errors. These are not reasons to avoid injectables, but they are reasons to get proper training.

A 2019 study by Defreyne et al. in LGBT Health found that injectable estradiol formulations were associated with higher peak estradiol levels compared to oral routes, which can be a benefit or a concern depending on the patient's cardiovascular risk profile and monitoring situation. Talk to a provider who actually knows transgender hormone therapy, not just a general practitioner who's never prescribed it.